Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lung Capacity01:47

Lung Capacity

56.3K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.3K
Pleura of the Lungs01:13

Pleura of the Lungs

7.2K
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
7.2K
Genetic Screens02:46

Genetic Screens

5.7K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.7K
Gross Anatomy of the Lungs01:17

Gross Anatomy of the Lungs

4.7K
The lungs are a pair of vital organs connected to the trachea via the left and right bronchi. The base of these organs meets the dome-shaped muscle known as the diaphragm. Encased by the pleurae, the lungs contact the mediastinum. The right lung is shorter yet wider, and has a larger volume than the left lung. The left lung has an indentation known as the cardiac notch. The superior region of the lungs is referred to as the apex, whereas the base is the lower region near the diaphragm. The...
4.7K
Cancer02:18

Cancer

54.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.3K
What is Cancer?02:12

What is Cancer?

14.4K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Something old something new-introduction to the ninth edition TNM classification of lung cancer.

The British journal of radiology·2025
Same author

Evolution of continuing medical education in radiology: on-site vs remote.

Insights into imaging·2024
Same author

PD-L1 expression in patients with non-small-cell lung cancer is associated with sex and genetic alterations: A retrospective study within the Caucasian population.

Thoracic cancer·2024
Same author

Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial.

ESMO open·2023
Same author

Correlation of PD-L1 expression on tumour cells between diagnostic biopsies and surgical specimens of lung cancer in real life with respect to biopsy techniques and neoadjuvant treatment.

Journal of cancer research and clinical oncology·2022
Same author

[Value of CT and transthoracic lung ultrasound in patients with systemic sclerosis : Joint statement of the ÖRG/ÖGP/ÖGR/ÖGUM].

Zeitschrift fur Rheumatologie·2022
Same journal

[Modern mid-field magnetic resonance imaging in private practice : Field report].

Der Radiologe·2022
Same journal

[Incidental and leave me alone findings of abdominal organs-part 2 : Spleen, kidneys and adrenal glands and efferent urinary tracts].

Der Radiologe·2022
Same journal

[Imaging of the musculoskeletal system using low-field magnetic resonance imaging].

Der Radiologe·2022
Same journal

[Imaging of the lung using low-field magnetic resonance imaging].

Der Radiologe·2022
Same journal

[Incidental and "leave me alone" findings of abdominal organs-part 1 : Liver, gall ducts and pancreas].

Der Radiologe·2022
Same journal

[Economic aspects of low-field magnetic resonance imaging : Acquisition, installation, and maintenance costs of 0.55 T systems].

Der Radiologe·2022
See all related articles

Related Experiment Video

Updated: Feb 1, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

16.2K

[Lung cancer screening].

H Prosch1, L Ebner2

  • 1Univ. Klinik für Radiologie und Nuklearmedizin, Medizinische Universität Wien, Allgemeines Krankenhaus Wien, Währingergürtel 18-20, 1090, Wien, Österreich. helmut.prosch@meduniwien.ac.at.

Der Radiologe
|December 14, 2018
PubMed
Summary
This summary is machine-generated.

Low-dose CT screening significantly reduces lung cancer mortality. However, European healthcare systems require tailored lung cancer screening guidelines, distinct from US approaches, to ensure effective and cost-efficient implementation.

Keywords:
Cost efficacyHealth care systemsPulmonary nodulesRisk modelsStudy data

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

413
Instillation and Fixation Methods Useful in Mouse Lung Cancer Research
06:57

Instillation and Fixation Methods Useful in Mouse Lung Cancer Research

Published on: August 31, 2015

29.6K

Related Experiment Videos

Last Updated: Feb 1, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

16.2K
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

413
Instillation and Fixation Methods Useful in Mouse Lung Cancer Research
06:57

Instillation and Fixation Methods Useful in Mouse Lung Cancer Research

Published on: August 31, 2015

29.6K

Area of Science:

  • Pulmonology
  • Oncology
  • Radiology

Background:

  • The National Lung Screening Trial (NLST) demonstrated a 20% reduction in lung carcinoma mortality using low-dose CT screening.
  • Unlike the USA, Europe currently lacks systematic lung cancer screening programs.
  • Previous smaller European studies have not shown a significant reduction in lung cancer mortality.

Purpose of the Study:

  • To address the absence of systematic lung cancer screening in Europe.
  • To highlight the need for Europe-specific guidelines due to healthcare system differences.
  • To facilitate the development of quality-assured and cost-effective lung cancer screening programs in Europe.

Main Methods:

  • Review of the National Lung Screening Trial (NLST) findings.
  • Analysis of differences between European and US healthcare systems.
  • Consideration of results from European screening studies.

Main Results:

  • Low-dose CT screening is proven effective in reducing lung cancer mortality.
  • Direct transfer of US screening protocols to Europe is not feasible.
  • Development of tailored European guidelines is necessary.

Conclusions:

  • European screening studies are expected to provide valuable data for guideline development.
  • Customized lung cancer screening strategies are essential for Europe.
  • Implementing effective screening programs can reduce lung cancer mortality across Europe.